$GTHX

G1 Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$3.445 ▲3.453%

Delayed Price

VOLUME

1,168,588

DAY RANGE

-

52 WEEK

1.08 - 5

Key Metrics

Market Cap

172.64 M

Beta

2.21

Avg. Volume

2.07 M

Shares Outstanding

51.84 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates.

CEO: Mark Velleca

Website:

HQ: 700 Park Offices Drive Research Triangle Park, 27709 North Carolina

Related News